The FDA Law Blog

SEPTEMBER 22, 2024

The webinar largely consisted of summarizing the general requirements under Parts 803, 806 and 820.198, which we do not reproduce here ( but see another of our prior blog posts discussing these requirements and their applicable to LDTs in greater detail; you can also find FDA’s slides from the webinar here ). By Steven J.

FDA 64

FDA Labelling Communication 64

Pharma Marketing Network

APRIL 20, 2025

Introduction Is Big Pharma a villainous label or a misunderstood brand? This article explores the nuances of how this label affects pharmaceutical marketing and what brands can do to respond strategically. This includes explainer videos, thought leadership pieces, and interactive webinars that humanize the research process.

Labelling 52

Labelling Communication 52

pharmaphorum

OCTOBER 27, 2022

The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.

Communication 98

Communication Packaging Documentation Pharmaceutical Companies 98

pharmaphorum

OCTOBER 12, 2018

The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label. We’ll be looking at how digital and traditional approaches to medicine are being combined to improve patient outcomes.

Labelling 52

Labelling Communication Patient Care FDA 52

The FDA Law Blog

FEBRUARY 27, 2023

Comment topics suggested by DEA include the following: Whether the rule should limit the issuance of prescriptions for controlled medications to FDA-approved indications contained in the labeling for those medications. We will release exciting details of our upcoming webinar addressing telemedicine soon. Stay tuned.

Controlled Substances 59

Controlled Substances FDA Documentation Labelling 59

Pharma Marketing Network

FEBRUARY 19, 2025

Regulatory-Friendly Communication : Unlike social media ads, emails offer controlled messaging that aligns with compliance regulations. Drug names and indications must align with FDA-approved labeling. signing up for a webinar, downloading a whitepaper)? Click-Through Rate (CTR) : Are recipients engaging with links?

HIPAA 72

HIPAA FDA Labelling Communication 72

ISPE

JULY 19, 2023

and management communication strategy. In the years leading up to 2022, numerous publications were issued; networking events, webinars, and conferences were held; and regulatory panel discussions with regulators performed. ™ hackathons were established, and the ISPE Factory of the Year (FOYA) award category was created.

Documentation 98

Documentation FDA Labelling Communication 98